Journal Title：Diabetes Obesity & Metabolism

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

《糖尿病、肥胖和代謝》主要刊登臨床和實(shí)驗(yàn)藥理學(xué)和治療學(xué)雜志，涵蓋糖尿病、肥胖和代謝相關(guān)領(lǐng)域。該雜志優(yōu)先刊登高質(zhì)量的原創(chuàng)研究，報(bào)告新療法或現(xiàn)有療法（包括飲食、運(yùn)動和生活方式（非藥物）干預(yù)）對人類或動物和細(xì)胞系統(tǒng)代謝和內(nèi)分泌疾病任何方面的影響?！按x”可能與脂質(zhì)、骨骼和藥物代謝或內(nèi)分泌功能障礙的更廣泛方面有關(guān)。臨床前藥理學(xué)、藥代動力學(xué)研究、薈萃分析以及涉及藥物安全性和耐受性的研究也非常適合在該雜志上發(fā)表。原創(chuàng)研究可以作為主要論文或研究信函發(fā)表。

Diabetes Obesity & Metabolism創(chuàng)刊于1999年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵蓋醫(yī)學(xué) - 內(nèi)分泌學(xué)與代謝全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 一般,3-8周 ，影響因子指數(shù)5.4，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。